Studies of prognostic factors in end-stage renal disease: An epidemiological and statistical critique

2002 ◽  
Vol 39 (6) ◽  
pp. 1196-1205 ◽  
Author(s):  
Tammy Keough-Ryan ◽  
Tom Hutchinson ◽  
Brenda MacGibbon ◽  
Martin Senecal
2017 ◽  
Vol 2 (5) ◽  
pp. 905-912 ◽  
Author(s):  
Andrés Urrestarazú ◽  
Gabriela Otatti ◽  
Ricardo Silvariño ◽  
Mariela Garau ◽  
Ruben Coitiño ◽  
...  

Resuscitation ◽  
2015 ◽  
Vol 96 ◽  
pp. 153
Author(s):  
Valentin Georgescu ◽  
Georgeta Gugonea ◽  
Ioana Dimitriu ◽  
Oana Tudorache ◽  
Mirela Nicolau ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Rune Bjørneklett ◽  
Vilde Solbakken ◽  
Leif Bostad ◽  
Anne-Siri Fismen

Background. Classification of patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) into histological classes is useful for predicting a patient’s risk of progression to end-stage renal disease (ESRD). However, even in the worst prognostic group, the 5-year end-stage renal disease-free survival rate is as high as 50%. Objectives. To investigate those prognostic factors indicative of progression to ESRD in patients with ANCA-GN and sclerosing histology. Methods. Patients from the Norwegian Kidney Biopsy Registry between 1991 and 2012 who had biopsy verified pauci-immune glomerulonephritis, positive ANCA serology, and sclerosing histology were included. Cases with ESRD during follow-up were identified via linkage with the Norwegian Renal Registry. Potential prognostic factors with relevant cut-offs were compared in patients with and without progression to ESRD during follow-up. Results. Of 23 included patients, 10 progressed to ESRD. ESRD patients had a lower initial estimated glomerular filtration rate (eGFR; 21 versus 52 ml/min/1.73 m2) and a lower percentage of normal glomeruli (4% versus 15%). Five-year risks of ESRD with eGFR >15 versus ≤15 ml/min/1.73 m2 were 77% and 15%, with percentage normal glomeruli >10% versus ≤10%, 83% and 39%. Conclusions. eGFR and percentage of normal glomeruli are strong risk factors for ESRD in ANCA-GN with sclerosing histology.


2018 ◽  
Vol 33 (suppl_1) ◽  
pp. i408-i408
Author(s):  
Kharroubi Melek ◽  
Aouidia Raja ◽  
Gaid Hanene ◽  
Jerbi Mouna ◽  
Chargui Soumaya ◽  
...  

Amyloid ◽  
2004 ◽  
Vol 11 (1) ◽  
pp. 27-37 ◽  
Author(s):  
Luísa Lobato ◽  
Idalina Beirão ◽  
Manuela Silva ◽  
Isabel Fonseca ◽  
José Queirós ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document